EMC testing at an external company in Germany

Yesterday, EMC testing (electromagnetic compatibility testing) of Lumito's product, SCIZYS, began with an external independent testing company in Germany to obtain an external assessment that ensures the product meets all relevant requirements. The company has prepared well with Optronic Partner pr for the independent EMC test and is now ready. The EMC testing is a […]

Presentation of results from a pilot study using Lumito’s imaging technology

In December 2022, the scientific article "Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer" was published in Cancer Immunology Research. The lead author of the published article, Tommy Lidström, was at Lumito in mid-February to present the results as part of Lumito's first exclusive presentation held for potential end customers […]

Live demonstration of Lumito’s scanner confirmed problem-solving capabilities

We finally got to show our product, SCIZYS by Lumito, during a live demonstration where tissue images were scanned in Lumito's laboratory under the supervision of around ten researchers and pathologists from the Malmö/Lund area. The visitors saw the added value of our product and confirmed the problem that Lumito could potentially solve. Tommy Lidström, […]

Lumito on BioStock’s list of the 10 strongest life science stocks 2022

BioStock has listed this year's ten strongest Swedish life science stocks and taken a closer look at some companies to see what's behind the share price increases. Lumito is ranked third on the list:   "Lumito rises ahead of market launch   High up on this year's winners list we also find diagnostics company Lumito, […]

Reflections from the Digital Pathology & AI Congress. Lumito – New kid in town

Lumito participated with a booth of our own at the Digital Pathology & AI Congress in London in early December. The congress was attended by over 440 delegates and was held at a conference hotel at Heathrow. The delegates, primarily from Western Europe, were specifically interested in the digitalization of pathology with both research and […]

The scientific article “Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer” is now published in Cancer Immunology Research

The scientific article entitled "Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer" is now published in the scientific journal Cancer Immunology Research. The main objective of the journal is to publish the best new findings from leading experts in chemistry, biology and clinical science. The paper is written by Daniel […]

The pre-launch phase of SCIZYS by Lumito continues without interruption

The pre-launch phase, which started in Spring 2022, continues and is now intensified as planned. Lumito will be represented with its own stand at the Digital Pathology & AI Congress: Europe in London on December 7-8. The presence at the congress will be complemented by advertising and editorial in the international professional journal The Pathologist […]

The launch of SCIZYS by Lumito will be slightly delayed

As previously communicated, Lumito's ambition and plan has been to offer product for researchers use only by the end of 2022. Employees and production partners have together set the plan and worked hard and focused on fulfilling the ambition, which has been deemed fully realistic until now. Lumito therefore wishes to inform that the launch […]

Testing the Lumito scanner with the final product design

Lumito's research and development team has attended the operational testing of the company's scanner with the final product design at the Swedish partner, Optronics Partner pr. Since a few months ago Lumito is in the commercialization phase with production as an area of focus. The purpose of the briefing was to test all the scanner's functions […]